药物研发的新范式。 - Suppr

Suppr

超能文献

A new paradigm for drug development.

作者信息

Burki Talha

出版信息

Lancet Digit Health. 2020 May;2(5):e226-e227. doi: 10.1016/S2589-7500(20)30088-1. Epub 2020 Apr 28.

DOI:10.1016/S2589-7500(20)30088-1

PMID:32373787

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194950/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/064f/7194950/835644a5d732/fx1.jpg

相似文献

A new paradigm for drug development.药物研发的新范式。

Lancet Digit Health. 2020 May;2(5):e226-e227. doi: 10.1016/S2589-7500(20)30088-1. Epub 2020 Apr 28.

Big Data and Artificial Intelligence Modeling for Drug Discovery.大数据和人工智能在药物发现中的建模。

Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:573-589. doi: 10.1146/annurev-pharmtox-010919-023324. Epub 2019 Sep 13.

ChatGPT or LLM in next-generation drug discovery and development: pharmaceutical and biotechnology companies can make use of the artificial intelligence-based device for a faster way of drug discovery and development.ChatGPT或大型语言模型在下一代药物发现与开发中的应用：制药和生物技术公司可以利用这种基于人工智能的工具来实现更快的药物发现与开发方式。

Int J Surg. 2023 Dec 1;109(12):4382-4384. doi: 10.1097/JS9.0000000000000719.

How Artificial Intelligence Will Change Medicine.人工智能将如何改变医学。

Nature. 2019 Dec;576(7787):S48. doi: 10.1038/d41586-019-03845-1.

Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.人工智能要在药物研发中发挥作用，就需要闭环发现平台集成。

Expert Opin Drug Discov. 2019 Jan;14(1):1-4. doi: 10.1080/17460441.2019.1546690. Epub 2018 Nov 29.

Could advances in representation learning in Artificial Intelligence provide the new paradigm for data integration in drug discovery?人工智能中表示学习的进展能否为药物发现中的数据整合提供新范式？

Expert Opin Drug Discov. 2019 Mar;14(3):191-194. doi: 10.1080/17460441.2019.1573811. Epub 2019 Jan 30.

Geometric Deep Learning Autonomously Learns Chemical Features That Outperform Those Engineered by Domain Experts.几何深度学习自主学习的化学特征优于领域专家设计的特征。

Mol Pharm. 2018 Oct 1;15(10):4371-4377. doi: 10.1021/acs.molpharmaceut.7b01144. Epub 2018 Jul 7.

Does artificial intelligence have the potential to transform drug formulation development?人工智能有改变药物制剂研发的潜力吗？

J Control Release. 2019 Oct;311-312:326-327. doi: 10.1016/j.jconrel.2019.10.019. Epub 2019 Oct 14.

Has Drug Design Augmented by Artificial Intelligence Become a Reality?人工智能增强的药物设计是否成为现实？

Trends Pharmacol Sci. 2019 Nov;40(11):806-809. doi: 10.1016/j.tips.2019.09.004. Epub 2019 Oct 16.

How to rekindle drug discovery process through integrative therapeutic targeting?如何通过综合治疗靶点重新激发药物发现过程？

Expert Opin Drug Discov. 2018 Oct;13(10):893-898. doi: 10.1080/17460441.2018.1514010. Epub 2018 Aug 27.

引用本文的文献

From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes.从实验室到临床：人工智能如何重塑药物研发时间表和行业成果。

Pharmaceuticals (Basel). 2025 Jun 30;18(7):981. doi: 10.3390/ph18070981.

Value Addition to African Natural Product-Based Drug Discovery Initiatives.为基于非洲天然产物的药物发现计划增添价值。

J Nat Prod. 2025 Aug 22;88(8):2018-2028. doi: 10.1021/acs.jnatprod.5c00446. Epub 2025 Jul 29.

Digital Alchemy: The Rise of Machine and Deep Learning in Small-Molecule Drug Discovery.数字炼金术：小分子药物发现中机器学习与深度学习的兴起

Int J Mol Sci. 2025 Jul 16;26(14):6807. doi: 10.3390/ijms26146807.

The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials.人工智能在药物创新中的潜力：从药物发现到临床试验

Pharmaceuticals (Basel). 2025 May 25;18(6):788. doi: 10.3390/ph18060788.

Harnessing the Power of AI in Cell and Genetic Engineering.利用人工智能在细胞与基因工程中的力量。

Methods Mol Biol. 2025;2952:283-295. doi: 10.1007/978-1-0716-4690-8_17.

Developing muscarinic receptor M1 classification models utilizing transfer learning and generative AI techniques.利用迁移学习和生成式人工智能技术开发毒蕈碱受体M1分类模型。

Sci Rep. 2025 May 12;15(1):16486. doi: 10.1038/s41598-025-00972-w.

Precision Psychiatry for Obsessive-Compulsive Disorder: Clinical Applications of Deep Learning Architectures.强迫症的精准精神病学：深度学习架构的临床应用

J Clin Med. 2025 Apr 3;14(7):2442. doi: 10.3390/jcm14072442.

Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools.肿瘤学的变革：人工智能（AI）作为抗体设计与优化工具的作用。

Biomark Res. 2025 Mar 29;13(1):52. doi: 10.1186/s40364-025-00764-4.

Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.精神疾病中的迷幻药物：当前临床范围及基于深度学习的前沿观点

Adv Sci (Weinh). 2025 Apr;12(15):e2413786. doi: 10.1002/advs.202413786. Epub 2025 Mar 20.

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.利用人工智能到深度学习进行药物发现的不断变化的情况：最新进展、成功案例、合作与挑战。

Mol Ther Nucleic Acids. 2024 Aug 8;35(3):102295. doi: 10.1016/j.omtn.2024.102295. eCollection 2024 Sep 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验